NeutriSci International Inc.
TSX VENTURE : NU

NeutriSci International Inc.

February 11, 2015 08:00 ET

NeutriSci Announces Strategic Equity Partnership With Internationally Acclaimed Branding and Marketing Firm Brand Fever

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 11, 2015) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE:NU) is pleased to announce its marketing and branding partnership with Brand Fever Inc. ("Brand Fever"). As part of the partnership, Brand Fever will be receiving equity in NeutriSci, and will be initially focused on the global launch of NeuEnergy™.

Brand Fever was founded in Atlanta, Georgia by Vicky Jones in 1997 as a marketing and branding firm dedicated to becoming a source of bold ideas, visionary talent and fearless leadership. Brand Fever quickly became an award winning international agency with clients such as Coca-Cola, McDonalds, UPS, Cox Automotive, Odwalla Beverages and Dasani Water.

Vicky Jones, President & CEO of Brand Fever commented, "We are thrilled to partner with NeutriSci in debuting the global launch of NeuEnergy™, a 'smart energy' alternative that leads the way in offering consumers an energy solution that is not over-caffeinated. NeuEnergy™ is the result of new science that delivers a better experience with considerably less caffeine than a cup of coffee to an industry expected to grow to $19.7 billion. NeuEnergy™ has solved the reckless problem of highly-caffeinated energy products. We fully expect consumers to be thrilled with this smarter product - NeuEnergy™."

Brand Fever's (brandfeverinc.com) strengths begin with its brand and digital marketing resources that thrive on a culture of collaboration and innovation. Brand Fever transforms intelligence into brand strategy and creates well-executed brand strategies across all media platforms, positioning them for long-term success. It's an intuitive understanding cultivated in their team combined with insights from their experiences, behaviors, perceptions and needs that give Brand Fever, and the brands they work with, a competitive edge.

Vicky Jones brings that competitive and unique perspective to the work performed by Brand Fever. Whether directing a rebranding initiative for Cox Communications, creating an astounding multi-sensory exhibit for The Coca-Cola Company to employ at the McDonald's International Convention, completely revamping Coca-Cola Enterprises' website, or developing a national brand identity for Lydia Mondavi's exclusive Neiman Marcus cosmetic line, Mrs. Jones serves as a leader and coach. The firm's efforts are recognized year after year through industry awards and acknowledged by globally acclaimed clients who seek the thought leadership Vicky provides to build, promote and protect their brands. Her honest communication and ambitious expectations inspire her staff to push beyond convention, and will help to solidify NeuEnergy's™ position in the rapidly changing multi-billion dollar consumable energy supplement space.

NeuEnergy™ is a revolutionary energy product designed to deliver enhanced focus and extended mental clarity with no sugar, calories or the typical crash associated with popular energy products. The efficacy of NeuEnergy™ is based scientifically on a molecular combination of pTeroPure® pterostilbene and a low dose of caffeine. The resulting co-crystal provides a novel, next-generation alternative to high-dose caffeine products and is the base ingredient of NeuEnergy™. In clinical studies, the co-crystal ingredient demonstrated a significantly more efficient cellular uptake when compared to standard caffeine alone.

Glen Rehman, President of NeutriSci, stated, "Brand Fever has exceeded all of our expectations; providing NeutriSci with a revolutionary go to market strategy and an immense catalog of ideas and concepts that we are excited to implement. We are fortunate and excited to have Vicky and her team as a true equity partner as we move towards the global launch of NeuEnergy™. Mrs. Jones's desire to have an equity stake in NeutriSci clearly demonstrates her belief in NeuEnergy™ and the ultimate success of the Company." Subject to TSXV approval, NeutriSci will issue 200,000 common shares in connection with the establishment of the partnership with Brand Fever.

On Behalf of the Board of Directors of NeutriSci International Inc.

Glen Rehman, President

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men's prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, Mass Market and Supermarket retailers. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Contact Information